Gains on chromosome arm 9q represent a novel and independent marker of adverse prognosis in multiple myeloma patients receiving upfront high-dose chemotherapy and autologous stem cell transplantation.

被引：0

作者：

Liebisch, P

Benner, A

Tschajka, K

Wendl, C

Goldschmidt, H

Döhner, H

机构：

[1] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany

[2] German Canc Res Ctr, Cent Unit Biostat, Heidelberg, Germany

[3] Univ Hosp Heidelberg, Med Klin 5, Heidelberg, Germany

来源：

BLOOD | 2005年 / 106卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1559

引用

页码：447A / 447A

页数：1

共 50 条

[1] Gains on chromosome band 9q34 could represent a novel independent prognostic marker in multiple myeloma patients receiving high-dose chemotherapy with autologous stem cell transplantation [J].

Liebisch, P ;

Goldschmidt, H ;

Tschajka, K ;

Wendl, C ;

Benner, A ;

Dohner, H .

BLOOD, 2004, 104 (11) :313A-313A

[2] OUTCOMES OF FRAIL PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY/AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA [J].

Yohay, Stephanie ;

Oloyede, Temitope ;

Dhakal, Binod ;

D'Souza, Anita ;

Aijaz, Ayesha ;

Mohan, Meera ;

Narra, Ravi ;

Pasquini, Marcelo ;

Hamadani, Mehdi ;

Freeman, Ciara Louise ;

Akhtar, Othman Salim .

BONE MARROW TRANSPLANTATION, 2024, 59 :517-517

[3] High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma [J].

Gertz, Marie A. ;

Lacy, Martha Q. ;

Dispenzieri, Angela ;

Hayman, Suzanne R. ;

Kumar, Shaji K. .

EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) :343-360

[4] High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma [J].

Maisnar, V. ;

Hajek, R. ;

Scudla, V. ;

Gregora, E. ;

Buchler, T. ;

Tichy, M. ;

Kotoucek, P. ;

Kafkova, A. ;

Forraiova, L. ;

Minarik, J. ;

Radocha, J. ;

Blaha, V. ;

Maly, J. .

BONE MARROW TRANSPLANTATION, 2008, 41 (01) :51-54

[5] High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma [J].

V Maisnar ;

R Hájek ;

V Ščudla ;

E Gregora ;

T Büchler ;

M Tichý ;

P Kotouček ;

A Kafková ;

L Forraiová ;

J Minařík ;

J Radocha ;

V Bláha ;

J Malý .

Bone Marrow Transplantation, 2008, 41 :51-54

[6] High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting [J].

Lisenko, Katharina ;

Sauer, Sandra ;

Bruckner, Thomas ;

Egerer, Gerlinde ;

Goldschmidt, Hartmut ;

Hillengass, Jens ;

Schmier, Johann W. ;

Shah, Sofia ;

Witzens-Harig, Mathias ;

Ho, Anthony D. ;

Wuchter, Patrick .

BMC CANCER, 2017, 17

[7] High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting [J].

Katharina Lisenko ;

Sandra Sauer ;

Thomas Bruckner ;

Gerlinde Egerer ;

Hartmut Goldschmidt ;

Jens Hillengass ;

Johann W. Schmier ;

Sofia Shah ;

Mathias Witzens-Harig ;

Anthony D. Ho ;

Patrick Wuchter .

BMC Cancer, 17

[8] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA WITH RENAL FAILURE [J].

Pokrovskaya, O. ;

Mendeleeva, L. ;

Urnova, E. ;

Firsova, M. ;

Nareyko, M. ;

Kuzmina, L. ;

Rekhtina, I. ;

Tauson, I. ;

Varlamova, E. ;

Parovichnikova, E. ;

Savchenko, V. .

BONE MARROW TRANSPLANTATION, 2014, 49 :S345-S346

[9] CD56 as prognostic factor in patients with multiple myeloma treated by high-dose chemotherapy and autologous stem cell transplantation. [J].

Hundemer, M ;

Klein, U ;

Hose, D ;

Cremer, F ;

Raab, M ;

Moos, M ;

Ho, AD ;

Goldschmidt, H .

BLOOD, 2004, 104 (11) :271A-271A

[10] Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myeloma [J].

Yohay, Stephanie ;

Oloyede, Temitope ;

Kim, Soyoung ;

Fang, Xi ;